Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2012
07/10/2012US8216587 Method of vaccination
07/10/2012US8216584 Imaging, diagnosis and treatment of disease
07/10/2012US8216561 Polyacrylamide hydrogel for the treatment of incontinence and vesicouretal reflex
07/10/2012US8216560 Administering a potassium-binding polymer of a crosslinked ion exchange polymer having acid groups and an alpha/beta electronegative group in a bead form as an oral dosage; renal insufficiency; congestive heart failure; hyperkalemia; high preferential binding capaciity; stability; nonabsorbent; nontoxic
07/10/2012CA2645888C High molecular weight chelation structure
07/10/2012CA2638081C Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
07/10/2012CA2607844C Pegylated g-csf polypeptides and methods of producing same
07/10/2012CA2510893C Binding agents which inhibit myostatin
07/10/2012CA2499994C Abuse-resistant pharmaceutical compositions
07/10/2012CA2494915C Female hormone-containing patch
07/10/2012CA2479652C Crystalline micronisate of tiotropium bromide
07/10/2012CA2470207C Matrix film tablet with controlled release of natural mixtures of conjugated estrogens
07/10/2012CA2466529C Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs
07/10/2012CA2462930C Remodeling and glycoconjugation of peptides
07/10/2012CA2451603C Process for facilitating nucleic acid transfer
07/10/2012CA2446951C Polythiourea lipid derivatives
07/10/2012CA2440010C Powder inhaler formulations
07/10/2012CA2437940C Methods of treating diabetes mellitus
07/10/2012CA2435712C Universal carrier for targeting molecules to gb3 receptor expressing cells
07/10/2012CA2429543C Method for obtaining antigenic aggregates and the use thereof in formulations
07/10/2012CA2407675C Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs
07/10/2012CA2326499C Methods of selecting internalizing antibodies
07/10/2012CA2319327C Sterile complex of therapeutic peptide bond to a polysaccharide
07/10/2012CA2246501C Stabilised growth hormone formulation and method of preparation thereof
07/10/2012CA2211324C Recombinant human alpha-fetoprotein and uses thereof
07/06/2012CA2819663A1 Rapidly dispersing granules, orally disintegrating tablets and methods
07/06/2012CA2775393A1 Topical non-aqueous pharmaceutical formulations
07/05/2012WO2012092510A2 Ocular drug delivery system
07/05/2012WO2012092486A2 Modified release benzimidazole formulations
07/05/2012WO2012092421A2 Composition for intravascular delivery of therapeutic composition
07/05/2012WO2012092339A2 The design of hydrolytically releasable prodrugs for sustained release nanoparticle formulations
07/05/2012WO2012092305A2 Nanonized iron compositions and methods of use thereof
07/05/2012WO2012091718A1 Polymalic acid-based nanobiopolymer compositions and methods for treating cancer
07/05/2012WO2012091534A1 Antibacterial agent for treating infectious diseases of bacterial origin
07/05/2012WO2012091523A2 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
07/05/2012WO2012091518A2 Phospholipid nanoparticles for mr-induced high-intensity focused ultrasonic treatment and diagnosis, and method for producing same
07/05/2012WO2012091278A2 Nanoemulsion-type ophthalmic composition
07/05/2012WO2012091165A1 Method for utilizing monoterpene glycosyltransferase
07/05/2012WO2012091137A1 GENE THERAPEUTIC AGENT USING TNF-α, CD40L, AND GM-CSF IN COMBINATION
07/05/2012WO2012091136A1 Expression vector, method for producing carrier using same, and use of same
07/05/2012WO2012091090A1 Antipyretic/analgesic composition
07/05/2012WO2012091054A1 Liposome composition and process for production thereof
07/05/2012WO2012091049A1 Orally disintegrating tablet
07/05/2012WO2012091040A1 Decay-type nuclear particle for pharmaceutical formulation
07/05/2012WO2012091039A1 Particulate formulation
07/05/2012WO2012090994A1 Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate
07/05/2012WO2012090985A1 Aqueous ophthalmic composition
07/05/2012WO2012090623A1 Capsule for delivering bifidobacterium into large intestine and method for producing same
07/05/2012WO2012090322A1 Patch
07/05/2012WO2012090223A1 Poly(ether imine) dendrimers and uses thereof
07/05/2012WO2012090150A2 New cell-penetrating peptides and uses thereof
07/05/2012WO2012090070A2 Biodegradable drug delivery compositions
07/05/2012WO2012090018A1 Cellular hydration compositions containing cyclodextrins
07/05/2012WO2012089933A2 Sachet of algae and/or clays with heatable hydrating support for medical or cosmetic care use
07/05/2012WO2012089882A1 Pharmaceutical composition including hyaluronic acid and a zinc compound and corresponding bar on a stick and preparation method
07/05/2012WO2012089778A1 Pharmaceutical formulation comprising a biopharmaceutical drug
07/05/2012WO2012089768A1 System for the release of a therapeutic agent, pharmaceutical compositions containing it, the preparation and medical use thereof
07/05/2012WO2012089729A1 Improved powderous vitamin e formulations
07/05/2012WO2012089623A1 Topical localized isoxazoline formulation comprising glycofurol
07/05/2012WO2012089622A2 Topical localized isoxazoline formulation
07/05/2012WO2012089602A1 Small molecule conjugates for intracellular delivery of biologically active compounds
07/05/2012WO2012089352A1 Small molecule conjugates for intracellular delivery of nucleic acids
07/05/2012WO2012089256A1 Medicated patch for improved transdermal permeation of diclofenac diethylammonium
07/05/2012WO2012089220A1 Method for producing a water-soluble medicinal form of an antibiotic from the group consisting of rifamycins, and composition produced by said method
07/05/2012WO2012088608A1 Compositions comprising natriuretic peptides and methods of use thereof
07/05/2012WO2012067868A3 Coloring composition containing l-dopa and l-arginine and forming a non-covalent derivatization complex
07/05/2012WO2012061402A3 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
07/05/2012WO2012054923A3 Therapeutic nanoparticles with high molecular weight copolymers
07/05/2012WO2012054564A3 Anti-vegf antibody/fragment conjugated gold nanoparticles, and fabrication and therapeutic methods
07/05/2012WO2012052479A3 Brimonidine gel compositions and methods of use
07/05/2012WO2012051614A3 Delivery of hydrophobic bioactive agents
07/05/2012WO2012050359A3 Hydrogel particle coated with lipid and method for manufacturing same
07/05/2012WO2012040623A3 Nanostructured gels capable of controlled release of encapsulated agents
07/05/2012WO2012009448A3 Cationic polymer coated mesoporous silica nanoparticles and uses thereof
07/05/2012WO2012005594A3 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides
07/05/2012WO2011146852A3 Foam or particles for applications such as drug delivery
07/05/2012WO2011084366A3 Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions
07/05/2012US20120172796 Composition for intravascular delivery of therapeutic composition
07/05/2012US20120172631 Phosphatidyl oligoglycerols
07/05/2012US20120172525 Compositions containing inclusion complexes
07/05/2012US20120172457 Novel powdered polymer, preparation method thereof and use of same as a thickener
07/05/2012US20120172456 Engineered microparticles for macromolecule delivery
07/05/2012US20120172455 Functionalized water-soluble polyphosphazenes and uses thereof as modifiers of biological agents
07/05/2012US20120172454 Biodegradable drug delivery compositions
07/05/2012US20120172411 Novel trialkyl cationic lipids and methods of use thereof
07/05/2012US20120172364 Rate-controlled particles
07/05/2012US20120172342 Biotherapeutics For the Treatment of Infectious Diseases
07/05/2012US20120172317 Silk fibroin hydrogels and uses thereof
07/05/2012US20120171914 Hydroxyl-Terminated Thiocarbonate Containing Compounds, Polymers, and Copolymers, and Polyurethanes and Urethane Acrylics Made Therefrom
07/05/2012US20120171765 Factor VII or VIIa - Like Molecules
07/05/2012US20120171289 Delivery systems for bioactive agents
07/05/2012US20120171260 Stent And Delivery System With Reduced Chemical Degradation
07/05/2012US20120171256 Electrospun silk material systems for wound healing
07/05/2012US20120171254 Process and Apparatuses for Preparing Nanoparticle Compositions with Amphiphilic Copolymers and Their Use
07/05/2012US20120171249 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
07/05/2012US20120171248 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/05/2012US20120171244 Mucosal boosting following parenteral priming
07/05/2012US20120171229 Synthetic nanocarriers with reactive groups that release biologically active agents
07/05/2012US20120171184 Cellular hydration compositions
07/05/2012US20120171121 Rosette Nanotubes as Drug Delivery Agents
1 ... 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 ... 1712